Ads
related to: pfizer third dose- Dosing Information
See details instructions for use
for Zavzpret™ Rx nasal spray.
- Watch Videos
See instructional videos to help
you learn more about Zavzpret™.
- Download Resources
Get educational resources for your
practice and patients.
- Zavzpret™ OneSource
Your eligible, commercially insured
patients may save. T&Cs apply.
- See Events
See upcoming events and register
online today.
- Safety Information
Access Important Safety Information
to learn more.
- Dosing Information
Search results
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 9 hours agoWelford forecasts more than $9 billion in peak sales for datopotamab deruxtecan, which is part of a partnership with Daiichi Sankyo. Executives are...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 1 day agoModerna CEO Stéphane Bancel recently told Barron’s that launching the shots in August instead of...
Posts Claim Falsely That AstraZeneca Is Withdrawing Its COVID Vaccine Because of Blood Clots
The Dispatch via Yahoo News· 5 days agoBlood clotting was first identified as a risk of the vaccine by medical regulators more than three...
How the love story between von der Leyen and Pfizer turned sour
Euronews via Yahoo News· 4 days agoFrom making her Europe’s vaccine saviour to becoming a skeleton in her closet: All the ebbs and...
Arvinas and Pfizer Announce Updated Clinical Data from Phase 1b Trial of Vepdegestrant in...
Morningstar· 5 days ago– After six months of additional follow-up, clinical benefit rate (63%), overall response rate (41.9%), median progression-free survival (11.2 months), and safety profile of vepdegestrant in ...
FliRT, a group of COVID-19 variants, accounts for most US cases. How to stay safe
Delaware Online | The News Journal via Yahoo News· 4 days agoPeople who are moderately or severely immunocompromised may get additional doses of the...that there...
Vepdegestrant shows promise in breast cancer trial By Investing.com
Investing.com· 5 days agoArvinas, Inc. (NASDAQ: ARVN) and Pfizer Inc. (NYSE: NYSE:PFE) today announced continued positive...
Why This Biotech Just Launched — Again — After Its 166% Run
Investor's Business Daily· 1 day agoDyne studied drugs it calls DYNE-101 and DYNE-251 in patients with myotonic dystrophy type 1 and...
The Zacks Analyst Blog Highlights Stocks recently featured in the blog include: Novo Nordisk, Eli...
Zacks via Yahoo Finance· 1 day agoAfter all, Moderna was not the behemoth it is today. Until 2020-end, the company lacked a marketed...
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 6 days agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...